Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
99.27
+4.05 (4.25%)
At close: Jul 8, 2026, 4:00 PM EDT
97.29
-1.98 (-1.99%)
After-hours: Jul 8, 2026, 7:14 PM EDT
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $664.99 million as of July 8, 2026. Its market cap has increased by 241.64% in one year.
Market Cap
664.99M
Enterprise Value
497.11M
1-Year Change
241.64%
Ranking
Category
Stock Price
$99.27
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $664.99M, an increase of 140.80%. That is a compound annual growth rate of 14.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 664.99M | 52.39% |
| Dec 31, 2025 | 436.37M | 225.25% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CorMedix | 687.24M |
| Neurogene | 683.79M |
| 4D Molecular Therapeutics | 683.25M |
| Achieve Life Sciences | 675.50M |
| First Tracks Biotherapeutics | 671.15M |
| BridgeBio Oncology Therapeutics | 668.89M |
| AgomAb Therapeutics NV | 662.88M |
| Ginkgo Bioworks Holdings | 661.74M |